The companies will collaborate with AstraZeneca to advance local lab testing for a prostate cancer genomic instability ...

Beckman Coulter Diagnostics appoints Catherine Jennings, formerly of Boston Scientific as president to lead global operations ...

Keck Medicine of USC has begun a trial to assess a blood test for early breast cancer detection, evaluating its use alongside ...

Aignostics launches HETA Clinical, an AI suite for assessing H&E slide quality and tumor content, aiming to reduce failed ...

Nabsys launches RepX, a pipeline on its Navigator platform that analyzes up to 23 disease loci in one run using Electronic ...

Modeling presented at ACG 2026 shows Guardant Health’s blood-based colorectal cancer screening averts more deaths and ...

Delve Bio launched Delve Detect Plasma, a blood-based mNGS assay that detects over 68,000 pathogens with next-day results, ...

A peer-reviewed study validates Gnosis' EdenDx cervical sample test, showing 96.8% specificity for endometrial cancer ...

Biodesix is presenting data showing Nodify Lung assay’s integration with PET imaging and its impact on lung nodule diagnostic ...

Labcorp to acquire select BioReference Health assets from OPKO Health for $722 million, including labs, service centers, and ...

New research from Cleveland Diagnostics suggests cancer detection may improve by analyzing existing biomarkers differently, ...

Agilent will acquire digital pathology software provider Proscia, expanding Agilent’s presence in digital pathology workflows ...